A method for generating antigen-presenting cells
CA 2487452 A1 · Owner: Merck Patent Gesellschaft Mit Beschraenkter Haftung · Inventors: Moll, Heidrun; Ramirez-Pineda, Robinson
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Described is a method for the generation of antigen-presenting cells (APC) preferably bone marrow-derived dendritic cells (BMDC) or peripheral bloodderived dendritic cells, as antigen carrier having immunostimulatory properties for anti-infective treatment comprising the steps of (a) pulsing the APC with antigen and (b) treating the APC with a CpG oligonucleotide. Said APC are useful as an immune prophylactic or immune therapeutic agent against diseases like AIDS, tuberculosis, malaria or leishmaniasis.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 27, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 27, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 27, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.